Raymond Yu

1.2k total citations
22 papers, 919 citations indexed

About

Raymond Yu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Raymond Yu has authored 22 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Raymond Yu's work include Signaling Pathways in Disease (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Raymond Yu is often cited by papers focused on Signaling Pathways in Disease (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Raymond Yu collaborates with scholars based in United States, Italy and Cuba. Raymond Yu's co-authors include Grant Gallagher, Giorgio Cattoretti, Lourdes Mendez, Rita Shaknovich, Jingwei Yu, Yonghui Zhang, B. Belinda Ding, Nicholas J. Megjugorac, Jihong Dai and Teddy Yang and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Blood.

In The Last Decade

Raymond Yu

20 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raymond Yu United States 14 438 312 293 174 86 22 919
Artem Laktyushin Australia 7 311 0.7× 401 1.3× 498 1.7× 80 0.5× 93 1.1× 11 863
Baoxia Dong China 16 470 1.1× 327 1.0× 185 0.6× 82 0.5× 49 0.6× 39 951
Simona Rolla Italy 21 323 0.7× 471 1.5× 339 1.2× 223 1.3× 89 1.0× 43 1.0k
Ivan Bilić Austria 17 572 1.3× 786 2.5× 256 0.9× 75 0.4× 91 1.1× 33 1.4k
Severine Martin‐Lannerée France 13 325 0.7× 187 0.6× 144 0.5× 66 0.4× 53 0.6× 21 662
Deborah Hardie United Kingdom 10 382 0.9× 715 2.3× 206 0.7× 97 0.6× 91 1.1× 15 1.2k
Palaniswami Rathanaswami Canada 16 358 0.8× 420 1.3× 252 0.9× 49 0.3× 147 1.7× 21 1.2k
Syuichi Nakatsuru Japan 10 336 0.8× 523 1.7× 222 0.8× 114 0.7× 82 1.0× 10 1.0k
Khalid W. Kalim United States 11 592 1.4× 371 1.2× 297 1.0× 43 0.2× 64 0.7× 15 958
Nicholas C. Hsu Taiwan 15 317 0.7× 272 0.9× 236 0.8× 61 0.4× 123 1.4× 28 815

Countries citing papers authored by Raymond Yu

Since Specialization
Citations

This map shows the geographic impact of Raymond Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Yu more than expected).

Fields of papers citing papers by Raymond Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Yu. The network helps show where Raymond Yu may publish in the future.

Co-authorship network of co-authors of Raymond Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond Yu. A scholar is included among the top collaborators of Raymond Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond Yu. Raymond Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Li, Pan, Noah Rozich, Jianxin Wang, et al.. (2022). Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model. Cancer Letters. 539. 215722–215722. 20 indexed citations
4.
Lei, Ming, Ahmed Hassan, Qingtai Su, et al.. (2020). Abstract 5195: NBL-015, a next-generation fully human anti-claudin 18.2 antibody with enhanced ADCC and CDC for treating gastric and pancreatic cancers. Cancer Research. 80(16_Supplement). 5195–5195. 2 indexed citations
5.
Jahagirdar, Ravi, Sarah Attwell, Suzana Marušić, et al.. (2017). RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease. Molecular Pharmacology. 92(6). 694–706. 48 indexed citations
6.
Yu, Raymond, et al.. (2015). The Human IL-23 Receptor rs11209026 A Allele Promotes the Expression of a Soluble IL-23R–Encoding mRNA Species. The Journal of Immunology. 194(3). 1062–1068. 20 indexed citations
7.
Jahagirdar, Ravi, Haiyan Zhang, Salman Azhar, et al.. (2014). A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice. Atherosclerosis. 236(1). 91–100. 96 indexed citations
8.
Zhu, Hong‐Jian, Sara R. Guariglia, Raymond Yu, et al.. (2013). Mutation of SIMPLE in Charcot–Marie–Tooth 1C alters production of exosomes. Molecular Biology of the Cell. 24(11). 1619–1637. 84 indexed citations
9.
Campeau, Eric, Ravi Jahagirdar, Emily M. Gesner, et al.. (2013). Abstract LB-92: RVX-2135 is a novel, orally bioavailable epigenetic BET inhibitor that synergizes with cytarabine and idarubicin to inhibit proliferation of acute myeloid leukemia cells.. Cancer Research. 73(8_Supplement). LB–92. 1 indexed citations
10.
Yang, Teddy, Hong‐Jian Zhu, Raymond Yu, et al.. (2012). Ablation of Calcineurin Aβ Reveals Hyperlipidemia and Signaling Cross-talks with Phosphodiesterases. Journal of Biological Chemistry. 288(5). 3477–3488. 16 indexed citations
11.
Gallagher, Grant, et al.. (2010). The Crohn’s Disease protective SNP rs11209026 mediates alternative splicing in human IL23R. (51.14). The Journal of Immunology. 184(Supplement_1). 51.14–51.14.
12.
Gallagher, Grant, et al.. (2010). The Lambda Interferons: Guardians of the Immune–Epithelial Interface and the T-helper 2 Response. Journal of Interferon & Cytokine Research. 30(8). 603–615. 32 indexed citations
13.
Yu, Raymond & Grant Gallagher. (2010). 393 A Naturally-Occurring, Soluble Antagonist of Human IL-23 Inhibits the Development and In Vitro Function of Human TH17 Cells. Gastroenterology. 138(5). S–58. 3 indexed citations
14.
Yu, Raymond & Grant Gallagher. (2010). A Naturally Occurring, Soluble Antagonist of Human IL-23 Inhibits the Development and In Vitro Function of Human Th17 Cells. The Journal of Immunology. 185(12). 7302–7308. 34 indexed citations
15.
Dai, Jihong, Nicholas J. Megjugorac, Grant Gallagher, & Raymond Yu. (2009). IFN-λ1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells. Blood. 113(23). 5829–5838. 96 indexed citations
16.
Olabisi, Opeyemi A., Edward Nieves, Teddy Yang, et al.. (2008). Regulation of Transcription Factor NFAT by ADP-Ribosylation. Molecular and Cellular Biology. 28(9). 2860–2871. 84 indexed citations
17.
Yang, Teddy, Raymond Yu, Anissa Agadir, et al.. (2008). Integration of Protein Kinases mTOR and Extracellular Signal-Regulated Kinase 5 in Regulating Nucleocytoplasmic Localization of NFATc4. Molecular and Cellular Biology. 28(10). 3489–3501. 41 indexed citations
18.
19.
Ding, B. Belinda, Jingwei Yu, Raymond Yu, et al.. (2007). Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood. 111(3). 1515–1523. 238 indexed citations
20.
Yu, Raymond, et al.. (2000). Expression of ram-5 in the structural cell is required for sensory ray morphogenesis in Caenorhabditis elegans male tail. The EMBO Journal. 19(14). 3542–3555. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Artem Laktyushin Breakdown of academic impact, for papers by Baoxia Dong Breakdown of academic impact, for papers by Simona Rolla Breakdown of academic impact, for papers by Ivan Bilić Breakdown of academic impact, for papers by Severine Martin‐Lannerée Breakdown of academic impact, for papers by Deborah Hardie Breakdown of academic impact, for papers by Palaniswami Rathanaswami Breakdown of academic impact, for papers by Syuichi Nakatsuru Breakdown of academic impact, for papers by Khalid W. Kalim Breakdown of academic impact, for papers by Nicholas C. Hsu
Rankless by CCL
2026